ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • MSME Summit
  • Trending News
    • Viral News
    • Travel
    • People
    • Entertainment
    • Sports
  • More ...
    • VIDEOS
    • PHOTOS
BREAKING NEWS
  • Atal Pension Yojana rule change: Big setback for taxpayers - know how it will impact your savings
  • Home loans, EMIs to get more expensive: Now, this PSU bank hikes interest rates by .20%
  • Mask mandatory in Delhi as Covid-19 cases rise again: Check new rules and penalty
  • US inflation data: Break on 40-year peak, global markets rally - key highlights
  • Microsoft layoffs 2022: IT giant sacks around 200 more employees as recession fears rise
Read in App
Business News » Companies News

Dr Reddys to spend upto $300 million on R&D in FY 20

The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the sales for the quarter, said Saumen Chakraborty, President, CFO and global head (HR) of Dr Reddy.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Dr Reddys to spend upto $300 million on R&D in FY 20
Replying to a query, Israeli said the company during FY 20 expects to launch more than 30 products in the US market. Reuters

Dr Reddys Laboratories is planning to spend upto USD 300 million on research and development (R&D) during this financial year, a senior official of the company has said. President, CFO and global head (HR) of Dr Reddy's Saumen Chakraborty, during an 'earnings call', said the drug- maker spent USD 226 million during the last fiscal against USD 264 million in FY 18. The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the sales for the quarter, he said.

The spend is lowered by 16 per cent year-on-year and is flat on a sequential quarter basis. The spend for FY 19 is Rs 1,551 crore. That is USD 226 million as against USD 264 million in FY 18, Chakraborty said. "We expect the overall R&D for FY 20 would be in the range of USD 250 million to USD 300 million," he said replying to a query. The company would continue to focus on R&D for some interesting pipeline of proprietary products. But, on an overall basis, the R&D spend would be lower in proprietary products when compared to previous year, he further said.

Speaking at the meeting, chief operating officer of the company Erez Israeli said, "Now that we made the R&D organisation more efficient andcould handle more products with less cost, we want to continue with this plan of productivity to increase the R&D in order to ensure no fallbacks and no differentiated products."

Replying to a query, Israeli said the company during FY 20 expects to launch more than 30 products in the US market. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Dr Reddy's Laboratories
Written By: PTI
Updated: Mon, May 20, 2019
05:45 pm
New Delhi, PTI
RELATED NEWS
Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma
Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say
Dr Reddy's shares surge 8% post q4 earnings; What should investors do? Dr Reddy's shares surge 8% post q4 earnings; What should investors do?
Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30 Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30
Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months

LATEST NEWS

MSME exporters facing demand squeeze in global markets

Industry says new digital lending norms to help them scale up, become more responsible

OYO expansion in Europe: Acquires Denmark's holiday home chain Bornholmske Feriehuse

India to be fastest growing economy this year - What government source said

Apple iPhone 14 Pro Max, iPhone 14 Pro likely to be expensive than iPhone 13 Pro models - All you need to know

International jewellery show to generate Rs 50,000 crore biz in 4-6 months: GJEPC

Atal Pension Yojana rule change: Big setback for taxpayers - know how it will impact your savings

Next Bank Holiday August 2022: Independence Day on Monday; here is a full list of holidays this month in major Indian cities

Aamir Khan Movie Laal Singh Chaddha Review By Taran Adarsh: DISAPPOINTS! Lacks captivating screenplay, fire in totality - 2 star rating

UPSC NDA, NA 2 admit card 2022 released at upsc.gov.in; direct link to download and exam date

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2022. India Dot Com Private Limited. All Rights Reserved.
LIVE TV